Orexins in the regulation of the hypothalamic-pituitary-adrenal axis

Pharmacological Reviews

Volumn 58, Issue 1, 2006, Pages 46-57

  Spinazzi, Raffaella ^a   Andreis, Paola G ^a   Rossi, Gian Paolo ^a   Nussdorfer, Gastone G ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Section of Anatomy   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; ALDOSTERONE; BRAIN PROTEIN; CATECHOLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUROPEPTIDE RECEPTOR; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; PHOSPHOLIPASE C; PROTEIN KINASE C INHIBITOR;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CELL; ADRENAL CORTEX TUMOR; ADRENAL MEDULLA; ANTERIOR HYPOTHALAMUS; CATECHOLAMINE RELEASE; CELL GROWTH; FEEDING; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDIAN EMINENCE; MEDULLA OBLONGATA; NONHUMAN; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SLEEP; STRESS;

ANIMALS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; PITUITARY-ADRENAL SYSTEM; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 33644604425     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.58.1.4     Document Type: Review

References (129)

1. Ahima RS and Flier JS (2000) Leptin. Annu Rev Physiol 62:413-437.
2. Al-Barazanji KA, Wilson S, Baker J, Jessop DS, and Harbuz MS (2001) Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J Neuroendocrinol 13:421-424.
3. Ammoun S, Holmqvist T, Shariatmadari R, Oonk HB, Detheux M, Parmentier M, Åkerman KEO, and Kukkonen JP (2003) Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharmacol Exp Ther 305:507-514.
4. Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Hayashi Y, Sasano H, and Mouri T (2000) Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides 21:565-570.
5. Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, and Mouri T (2001) Immunoreactive orexin-A in human plasma. Peptides 22:139-142.
6. Baker JR, Cardinal K, Bober C, Taylor MM, and Samson WK (2003) NeuropeptideW acts in brain to control prolactin, corticosterone and growth hormone release. Endocrinology 144:2816-2821.
7. Barreiro ML, Pineda R, Navarro VM, Lopez M, Suominen JS, Pinilla L, Señaris R, Toppari J, Aguilar E, Dieguez C, et al. (2004) Orexin 1 receptor messenger ribonucleic acid expression and stimulation of testosterone secretion by orexin-A in rat testis. Endocrinology 145:2297-2306.
8. Beuckmann CT and Yanagisawa M (2002) Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med 80:329-342.
9. Blanco M, Garcia-Caballero T, Fraga M, Gallego R, Cuevas J, Forteza J, Beiras A, and Dieguez C (2002) Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas. Regul Pept 104:161-165.
10. Blanco M, Lopez M, Garcia-Caballero T, Gallego R, Vazquez-Boquete A, Morel G, Señaris R, Casanueva F, Dieguez C, and Beiras A (2001) Cellular localization of orexin receptors in human pituitary. J Clin Endocrinol Metab 86:1616-1619.
11. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, et al. (1997) Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage and testosterone. J Clin Endocrinol Metab 82:2904-2910.
12. Bornstein SR (1997) Is leptin a stress related peptide? Nat Med 3:397.
13. Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, and Scherbaum WA (1997) Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 46:1235-1238.
14. Brunton PJ and Russell JA (2003) Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats. J Neuroendocrinol 15:633-637.
15. Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JRS, Wilson S, and Williams G (2001) Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 50:105-112.
16. Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, Arch JR, Tadayyon M, Clapham JC, Wilding J, and Williams G (1999) Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 48:2132-2137.
17. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451.
18. Chen CT, Dun SL, Kwok EH, Dun NJ, and Chang JK (1999) Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 260:161-164.
19. Cluderay JE, Harrison DC, and Hervieu GJ (2002) Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept 104:131-144.
20. Crawley JN and Corwin RL (1994) Biological actions of cholecystokinin. Peptides 15:731-755.
21. Cutler DJ, Morris R, Sheridhar V, Wattam TA, Holmes S, Patel S, Arch JR, Wilson S, Buckingham RE, Evans ML, et al. (1999) Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides 20:1455-1470.
22. Dallman MF, Akana SF, Bhatnagar S, Bell ME, Choi S, Chu A, Horsley C, Levin N, Meijer O, Soriano LR, et al. (1999) Starvation: early signals, sensors and sequelae. Endocrinology 135:4015-4023.
23. Date Y, Mondal MS, Matsukura S, Ueta Y, Yamashita H, Kaiya H, Kangawa K, and Nakazato M (2000) Distribution of orexin/hypocretin in the rat median eminence and pituitary. Mol Brain Res 76:1-6.
24. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, and Nakazato M (1999) Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96:748-753.
25. De Lecea L, Kilduff TS, Peyron C, Gao XB, Foye PE, Danielson PE, Fukuhara C, Battenberg ELF, Gautvik VT, Bartlett FS, et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322-327.
26. De Lecea L and Sutcliffe JG (1999) The hypocretins/orexins: novel hypothalamic neuropeptides involved in different physiological systems. Cell Mol Life Sci 56:473-480.
27. Dyer CJ, Touchette KJ, Carroll JA, Allee GL, and Matteri RL (1999) Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on food intake in young pigs. Domest Anim Endocrinol 16:145-148.
28. Engelmann M, Landgraf R, and Wotjak CT (2004) The hypothalamic- neurohypophyseal system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol 25:132-149.
29. Ferguson AV and Samson WK (2003) The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 24:141-150.
30. Funahashi H, Hori T, Shimoda Y, Mizushima H, Ryushi T, Katoh S, and Shioda S (2000) Morphological evidence for neural interactions between leptin and orexin in the hypothalamus. Regul Pept 92:31-35.
31. Glasow A and Bornstein SR (2000) Leptin and the adrenal gland. Eur J Clin Invest 3:39-45.
32. Glasow A, Haidan A, Hilbers U, Breidert M, Gillespie J, Scherbaum WA, Chrousos GP, and Bornstein SR (1998) Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. J Clin Endocrinol Metab 83:4459-4466.
33. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, and Flier JS (1997) Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 138:3859-3863.
34. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, and Leslie RA (2001) Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103:777-797.
35. Hochól A, Albertin G, Nussdorfer GG, Spinazzi R, Ziolkowska A, Rucinski M, and Malendowicz LK (2004) Effects of neuropeptides B and W on the secretion and growth of rat adrenocortical cells. Int J Mol Med 14:843-847.
36. Holmqvist T, Åkerman KEO and Kukkonen JP (2001) High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides. Neurosci Lett 305:177-180.
37. Holmqvist T, Johansson L, Östman M, Ammount S, Åkerman KEO, and Kukkonen JP (2005) OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms. J Biol Chem 280:6570-6579.
38. Horvath T, Diano S, and Van den Pol AN (1999) Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19:1072-1087.
39. Hungs M and Mignot E (2001) Hypocretin/orexin, sleep and narcolepsy. Bioessays 23:397-408.
40. Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, and Murakami N (2000) Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270:318-323.
41. Jaszberényi M, Bujdosó E, Pataki I, and Telegdy G (2000) Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 12:1174-1178.
42. Jaszberényi M, Bujdosó E, and Telegdy G (2001) The role of neuropeptide Y in orexin-induced hypothalamic-pituitary-adrenal activation. J Neuroendocrinol 13:438-441.
43. Jöhren O, Brüggemann N, Dendorfer A, and Dominiak P (2003) Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors. Endocrinology 144:1219-1225.
44. Jöhren O, Brüggemann N, and Dominiak P (2004) Orexins (hypocretins) and adrenal function. Horm Metab Res 36:370-375.
45. Jöhren O, Neidert SJ, Kummer M, Dendorfer A, and Dominiak P (2001) Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142:3324-3331.
46. Kane JK, Tanaka H, Parker SL, Yanagisawa M, and Li MD (2000) Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y and secretin. Biochem Biophys Res Commun 272:959-965.
47. Kanenishi K, Ueno M, Momose S, Kuwabara H, Tanaka H, Sato C, Kobayashi T, Hino O, Sakamoto H, and Hata T (2004) Prepro-orexin mRNA expression in the rat brain is increased during pregnancy. Neurosci Lett 368:73-77.
48. Karteris E, Chen J, and Randeva HS (2004) Expression of human prepro-orexin and signaling characteristics of orexin receptors in the male reproductive system. J Clin Endocrinol Metab 89:1957-1962.
49. Karteris E, Machado RJ, Chen J, Zervou S, Hillhouse EW, and Randeva HS (2005) Food deprivation differentially modulates orexin receptor expression and signaling in rat hypothalamus and adrenal cortex. Am J Physiol 288:E1089-E1100.
50. Karteris E, Randeva HS, Grammatopoulos DK, Jaffe RB, and Hillhouse EW (2001) Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. J Clin Endocrinol Metab 86:4512-4519.
51. Kastin AJ and Akerstrom V (1999) Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 289:219-223.
52. Kawada Y, Ueno S, Asayama K, Tsutsui M, Utsunomiya K, Toyohira Y, Morisada N, Tanaka K, Shirahata A, and Yanagihara N (2003) Stimulation of catecholamine synthesis by orexin-A in bovine adrenal medullary cells through orexin receptor 1. Biochem Pharmacol 66:141-147.
53. Kok SW, Roelfsema F, Overeem S, Lammers GJ, Strijers RL, Frölich M, Meinders AE, and Pijl H (2002) Dynamics of the pituitary-adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker. J Clin Endocrinol Metab 87:5085-5091.
54. Khorooshi RMH and Klingenspor M (2005) Neuronal distribution of melanin-concentrating hormone, cocaine- and amphetamine-regulated transcript and orexin B in the brain of the Djungarian hamster (Phodopus sungorus). J Chem Neuroanat 29:137-148.
55. Kreegipuu A, Blom N, and Brunak S (1999) PhosphoBase, a database of phosphorylation sites: release 2.0. Nucleic Acids Res 27:237-239.
56. Krysiak R, Obuchowicz E, and Herman ZS (1999) Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 140:130-136.
57. Kukkonen JP, Holmqvist T, Ammoun S, and Åkerman KEO (2002) Functions of the orexinergic/hypocretinergic system. Am J Physiol 283:C1567-C1591.
58. Kuru M, Ueta Y, Serino R, Nakazato M, Yamamoto Y, Shibuya I, and Yamashita H (2000) Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 11:1977-1980.
59. 2+ entry: evidence for involvement of TRPC channels and protein kinase C regulation. J Biol Chem 280:1771-1781.
60. Leal-Cerro A, Considine RV, Peino R, Venegas E, Astorga R, Casanueva FF, and Dieguez C (1996) Serum immuno-reactive leptin levels are increased in patients with Cushing's syndrome. Horm Metab Res 28:711-713.
61. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, De Jong PJ, Nishino S, and Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376.
62. Lopez M, Señaris R, Gallego R, Garcia-Caballero T, Lago F, Seoane L, Casanueva F, and Dieguez C (1999) Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 140:5991-5994.
63. Lopez M, Seoane L, Garcia MC, Lago F, Casanueva FF, Señaris R, and Dieguez C (2000) Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 269:41-45.
64. Lopez M, Seoane L, Señaris RM, and Dieguez C (2001) Prepro-orexin mRNA levels in the rat hypothalamus and orexin receptor mRNA levels in the rat hypothalamus and adrenal gland are not influenced by the thyroid status. Neurosci Lett 300:171-175.
65. Lu XY, Bagnol D, Burke S, Akil H, and Watson SJ (2000) Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 37:335-344.
66. 2+ influx pathway necessary for coupling to phospholipase C. J Biol Chem 275:30806-30812.
67. Malendowicz LK, Hochól A, Ziolkowska A, Nowak M, Gottardo L, and Nussdorfer GG (2001a) Prolonged orexin administration stimulates steroid-hormone secretion, acting directly on the rat adrenal gland. Int J Mol Med 7:401-404.
68. Malendowicz LK, Jedrzejczak N, Belloni AS, Trejter M, Hochól A, and Nussdorfer GG (2001b) Effects of orexins A and B on the secretory and proliferative activity of immature and regenerating rat adrenal glands. Histol Histopathol 16:713-717.
69. Malendowicz LK, Nowak M, Gottardo L, Tortorella C, Majchrzak M, and Nussdorfer GG (2001c) Cholecystokinin stimulates aldosterone secretion from dispersed rat zona glomerulosa cells, acting through cholecystokinin receptors 1 and 2 coupled with the adenylate cyclase-dependent cascade. Endocrinology 142:4251-4255.
70. Malendowicz LK, Spinazzi R, Majchrzak M, Nowak M, Nussdorfer GG, Ziolkowska A, Macchi C, and Trejter M (2003) Effects of prolonged cholecystokinin administration on rat pituitary-adrenocortical axis: role of the CCK receptor subtypes 1 and 2. Int J Mol Med 12:903-909.
71. Malendowicz LK, Tortorella C, and Nussdorfer GG (1999a) Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J Steroid Biochem Mol Biol 70:185-188.
72. Malendowicz LK, Tortorella C, and Nussdorfer GG (1999b) Acute effects of orexins A and B on the rat pituitary-adrenocortical axis. Biomed Res 20:301-304.
73. Mantzoros CS and Moschos SJ (1998) Leptin: in search of role(s) in human physiology and pathophysiology. Clin Endocrinol (Oxford) 49:551-567.
74. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, and Elmqvist JK (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6-25.
75. Matsumura K, Tsuchihashi T, and Abe I (2001) Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension 37:1382-1387.
76. Mazzocchi G, Malendowicz LK, Aragona F, Rebuffat P, Gottardo L, and Nussdorfer GG (2001a) Human pheochromocytomas express orexin receptor type 2 gene and display an in vitro secretory response to orexins A and B. J Clin Endocrinol Metab 86:4818-4821.
77. Mazzocchi G, Malendowicz LK, Aragona F, Spinazzi R, and Nussdorfer GG (2004) Cholecystokinin (CCK) stimulates aldosterone secretion from human adrenocortical cells via CCK2 receptors coupled to the adenylate cyclase/protein kinase A signaling cascade. J Clin Endocrinol Metab 89:1277-1284.
78. Mazzocchi G, Malendowicz LK, Gottardo L, Aragona F, and Nussdorfer GG (2001b) Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade. J Clin Endocrinol Metab 86:778-782.
79. Mazzocchi G, Rebuffat P, Ziolkowska A, Rossi GP, Malendowicz LK, and Nussdorfer GG (2005) G protein receptors (GPR) 7 and 8 are expressed in human adrenocortical cells and their endogenous ligands neuropeptides B and W enhance cortisol secretion by activating adenylate cyclase- and phospholipase C-dependent signaling cascades. J Clin Endocrinol Metab 90:3466-3471.
80. McGranaghan PA and Piggins HD (2001) Orexin A-like immunoreactivity in the hypothalamus and thalamus of the Syrian hamster (Mesocricetus auratus) and Siberian hamster (Phodopus sungorus), with special reference to circadian structures. Brain Res 904:234-244.
81. Meier CA (1998) Orexins and anorexins: thoughts for food. Eur J Endocrinol 139:148-149.
82. Mignot E (2001) A commentary on the neurobiology of the hypocretin/orexin system. Neuropsychopharmacology 25:S5-S13.
83. Mitsuma T, Hirooka Y, Kayama M, Mori Y, Yokoi Y, Rhue N, Ping J, Izumi M, Ikai R, Adachi K, et al. (2000) Radioimmunoassay for orexin A. Life Sci 66:897-904.
84. Moreno G, Perello M, Gaillard RC, and Spinedi E (2005) Orexin A stimulates hypothalamic-pituitary-adrenal (HPA) axis function, but not food intake, in the absence of full hypothalamic NPY-ergic activity. Endocrine 26:99-106.
85. Nakabayashi M, Suzuki T, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Date F, Takeyama J, Darnel AD, Moriya T, et al. (2003) Orexin-A expression in human peripheral tissues. Mol Cell Endocrinol 205:43-50.
86. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, and Goto K (1999) Distribution of orexin neurons in the adult rat brain. Brain Res 827:243-260.
87. Nanmoku T, Isobe K, Sakurai T, Yamanaka A, Takekoshi K, Kawakami Y, Goto K, and Nakai T (2002) Effects of orexin on cultured porcine adrenal medullary and cortex cells. Regul Pept 104:125-130.
88. Nanmoku T, Isobe K, Sakurai T, Yamanaka A, Takekoshi K, Kawakami Y, Ishii K, Goto K, and Nakai T (2000) Orexins suppress catecholamine synthesis and secretion in cultured PC12 cells. Biochem Biophys Res Commun 274:310-315.
89. Nishino S, Ripley B, Overeem S, Lammers GJ, and Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40.
90. Nowak M, Hochól A, Tortorella C, Jedrzejczak N, Ziolkowska A, Nussdorfer GG, and Malendowicz LK (2000) Modulatory effects of orexins on the function of rat pituitary-adrenocortical axis under basal and stressful conditions. Biomed Res 21:89-93.
91. Nussdorfer GG (1996) Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol Rev 48:495-530.
92. Nussdorfer GG, Rossi GP, Malendowicz LK, and Mazzocchi G (1999) Autocrine-paracrine endothelin system in the physiology and pathology of steroid secreting tissues. Pharmacol Rev 51:403-438.
93. Nussdorfer GG, Spinazzi R, and Mazzocchi G (2005) Cholecystokinin (CCK) and adrenal-cortex secretion. Vitam Horm 71:433-453.
94. Ouedraogo R, Näslund E, and Kirchgessner AL (2003) Glucose regulates the release of orexin-A from the endocrine pancreas. Diabetes 52:111-117.
95. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6:991-997.
96. Porkka-Heiskanen T, Kalinchuk A, Alanko L, Huhtaniemi I, and Stenberg D (2004) Orexin A and B levels in the hypothalamus of female rats: the effects of the estrous cycle and age. Eur J Endocrinol 150:737-742.
97. Porter RA, Chan WN, Coulton S, Johns A, Hadley MS, Widdowson K, Jerman JC, Brough SJ, Coldwell M, Smart D, et al. (2001) 1,3-Biarylureas as selective nonpeptide antagonists of the orexin-1 receptor. Bioorg Med Chem Lett 11:1907-1910.
98. Pralong FP, Roduit R, Waeber G, Castillo E, Mosimann F, Thorens B, and Gaillard RC (1998) Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland. Endocrinology 139:4264-4268.
99. Randeva HS, Karteris E, Grammatopoulos DK, and Hillhouse EW (2001) Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. J Clin Endocrinol Metab 86:4808-4813.
100. Remesar X, Rafecas I, Fernandez-Lopez JA, and Alemany M (1997) Leptin. Med Res Rev 17:225-234.
101. Renshaw D and Hinson JP (2001) Neuropeptide Y and the adrenal gland: a review. Peptides 22:429-438.
102. Rouet-Benzineb P, Rouyer-Fessard C, Jarry A, Avondo V, Pouzet C, Yanagisawa M, Laboisse C, Laburthe M, and Voisin T (2004) Orexins acting at native OX1 receptor in colon cancer and neuroblastoma cells or at recombinant OX1 receptor suppress cell growth by inducing apoptosis. J Biol Chem 279:45875-45886.
103. Russell SH, Small CJ, Dakin CL, Abbott CR, Morgan DGA, Ghatei MA, and Bloom SR (2001) The central effects of orexin-A in the hypothalamic-pituitary- adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol 13:561-566.
104. Sakurai T (1999) Orexin and orexin receptors: implication in feeding behaviour. Regul Pept 85:25-30.
105. Sakurai T (2005) Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regul Pept 126:3-10.
106. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.
107. Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M, and Goto K (1999) Structure and function of human prepro-orexin gene. J Biol Chem 274:17771-17776.
108. Samson WK and Resch ZT (2000) The hypocretin/orexin story. Trends Endocrinol Metab 11:257-262.
109. Samson WK and Taylor MM (2001) Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol 281:R1140-R1145.
110. Samson WK, Taylor MM, Follwell M, and Ferguson AV (2002) Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 104:97-103.
111. Siegel JM, Moore R, Thannickal T, and Nienhuis R (2001) A brief history of hypocretin/ orexin and narcolepsy. Neuropsychopharmacology 25:S14-S20.
112. Smart D, Jerman JC, Brough SJ, Rushton SL, Murdock PR, Jewitt F, Elshourbagy NA, Ellis CE, Middlemiss DN, and Brown F (1999) Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol 128:1-3.
113. Smart D, Sabido-David C, Brough SJ, Jewitt F, Johns A, Porter RA, and Jerman JC (2001) SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 132:1179-1182.
114. Spinazzi R, Andreis PG, and Nussdorfer GG (2005a) Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions. Int J Mol Med 15:3-13.
115. Spinazzi R, Rucinski M, Neri G, Malendowicz LK, and Nussdorfer GG (2005b) Prepro-orexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas and orexins stimulate in vitro cortisol secretion and growth of tumor cells. J Clin Endocrinol Metab 90:3544-3549.
116. Spinazzi R, Ziolkowska A, Neri G, Nowak M, Rebuffat P, Nussdorfer GG, Andreis PG and Malendowicz LK (2005c) Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades. Int J Mol Med 15:847-852.
117. Stricker-Krongrad A and Beck B (2002) Modulation of hypothalamic hypocretin/ orexin mRNA expression by glucocorticoids. Biochem Biophys Res Commun 296:129-133.
118. Taheri S and Bloom S (2001) Orexins/hypocretins: waking up the scientific world. Clin Endocrinol (Oxford) 54:421-429.
119. Taylor MM and Samson WK (2003) The other side of the orexins: endocrine and metabolic actions. Am J Physiol 284:E13-E17.
120. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, and Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469-474.
121. Trivedi P, Yu H, Mac Neil DJ, Van der Ploeg LH, and Guan XM (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438:71-75.
122. Van den Pol AN, Gao XB Obrietan K, Kilduff TS and Belousov AB (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18:7962-7971.
123. Wauters M, Considine RV, and Van Gaal LF (2000) Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143:293-311.
124. Weise M, Abad V, Considine RV, Nieman L, and Rother KI (1999) Leptin secretion in Cushing's syndrome: preservation of diurnal rhythm and absent response to corticotropin-releasing hormone. J Clin Endocrinol Metab 84:2075-2079.
125. Willie JT, Chemelli RM, Sinton CM, and Yanagisawa M (2001) To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24:429-458.
126. Wolf G (1998) Orexins: a newly discovered family of hypothalamic regulators of food intake. Nutr Rev 56:172-189.
127. Yamamoto Y, Ueta Y, Hara Y, Serino R, Nomura M, Shibuya I, Shirahata A, and Yamashita H (2000) Postnatal development of orexin/hypocretin in rats. Mol Brain Res 78:108-119.
128. Zhang S, Blache D, Vercoe PE, Adam CL, Blackberry MA, Findlay PA, Eidne KA, and Martin GB (2005) Expression of orexin receptors in the brain and peripheral tissues of the male sheep. Regul Pept 124:81-87.
129. Ziolkowska A, Spinazzi R, Albertin G, Nowak M, Malendowicz LK, Tortorella C, and Nussdorfer GG (2005) Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor. J Steroid Biochem Mol Biol 96:423-429.